Drug Approval | September 22, 2023
Dishman Carbogen Amcis updates on inspection by EDQM and AIFA
The company's Bavla site was successfully jointly inspected by the EDQM and Italian Medicines Agency (AIFA)
The company's Bavla site was successfully jointly inspected by the EDQM and Italian Medicines Agency (AIFA)
The campaign for the digital film is being amplified across various digital media platforms such as YouTube, Facebook, Instagram, Twitter, and LinkedIn
The centralized marketing authorization granted by the EC is valid in all EU Member States as well as in the European Economic Area (EEA) countries Iceland, Liechtenstein and Norway
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
The Government of India continues to prioritise initiatives aimed at enhancing the accessibility and equity of health services
Opinion granted based on positive disease-free survival results from the Phase 3 KEYNOTE-091 trial
JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions
This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US
This is a strategic acquisition for Cipla South Africa to unlock the future growth opportunities in the South African market
Amneal’s site in Matoda is one of the company’s 12 pharmaceutical manufacturing facilities
Subscribe To Our Newsletter & Stay Updated
